GI Partners Acquires Majority Stake in Clinical Ink
August 4, 2020
GI Partners will acquire a majority interest in Clinical Ink, a global clinical trial technology company headquartered in Horsham, Pennsylvania. The private investment firm will partner with Clinical Ink's management to accelerate product innovation, expand capabilities internationally, and pursue growth; existing investor NovaQuest will remain a minority shareholder. The transaction was expected to close in Q3 2020, subject to customary closing conditions.
- Buyers
- GI Partners
- Targets
- Clinical Ink
- Industry
- Cloud & SaaS
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
GI Partners Acquires Majority Stake in eClinical Solutions
September 12, 2024
Cloud & SaaS
GI Partners has made a majority investment in eClinical Solutions, a Boston‑area provider of AI‑enabled clinical data cloud software and biometrics services. The capital will support product roadmap expansion, embedded AI capabilities, and global growth while Summit Partners and the founders retain minority stakes.
-
ClinicalMind Acquires 11TEN Innovation Partners
April 23, 2024
Healthcare Services
ClinicalMind, a healthcare marketing and communications firm based in New York, has acquired 11TEN Innovation Partners, an Atlanta-based healthcare strategy and innovation consulting firm. The acquisition combines ClinicalMind's medical communications, training, and technology capabilities with 11TEN's commercial strategy and innovation ecosystem to offer integrated end-to-end services for life sciences clients.
-
Kohlberg Acquires Majority Stake in Worldwide Clinical Trials
August 7, 2023
Healthcare Services
An affiliate of Kohlberg & Company agreed to acquire a majority stake in Worldwide Clinical Trials, a global contract research organization (CRO) headquartered in Research Triangle Park, North Carolina. The transaction is a recapitalization in which prior investor TJC, L.P. retains a meaningful minority equity stake; terms were not disclosed. Kohlberg will partner with Worldwide's management (Matt Jennings to become chairman) to support continued growth of the company's clinical trial and bioanalytical capabilities.
-
Trinity Hunt Partners Makes Majority Investment in Centricity Research
May 31, 2023
Healthcare Services
Trinity Hunt Partners has made a majority investment in Centricity Research, a North American integrated clinical research organization that conducts Phase I–IV trials across over 40 therapeutic areas. Trinity Hunt said it will partner with Centricity’s management to invest in organic growth and acquire complementary clinical research site businesses to expand capabilities and therapeutic coverage across the U.S. and Canada.
-
Summit Partners Makes Growth Equity Investment in eClinical Solutions
January 21, 2020
Cloud & SaaS
Summit Partners has made a minority growth equity investment in eClinical Solutions LLC to support expansion of the company's cloud-based Clinical Data Hub platform, elluminate, and its elluminate-enabled data services. Summit Partners principals Mark deLaar and Jesse Lane have joined eClinical Solutions' board as part of the transaction to help accelerate product and market growth.
-
CSG Systems International Acquires Business Ink
March 5, 2018
Marketing & Advertising
CSG has acquired Business Ink, an Austin-based provider of outsourced, multi-channel customer communications services, expanding CSG's customer communications capabilities and reach into new vertical markets. Business Ink serves more than 500 organizations across healthcare, financial services, professional services and utilities and has operations in Austin, Fort Worth and Charlotte.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.